Composite outcomes are commonly used in critical care trials to estimate the treatment effect
of an intervention. A significant limitation of classical analytic approaches is that they assign …

BACKGROUND: Cardiovascular trials often use a composite end point and a time-to-first
event model. We sought to compare edoxaban versus warfarin using the win ratio, which …

Background Sacubitril–valsartan has been widely reported for reducing the risk of
cardiovascular death and improving left ventricular remodeling in patients with heart failure …

The win ratio has important limitations. First, it is not always clear how to prioritize
component events. Is myocardial infarction worse than stroke? Is 1 early hospitalization …

Coronary artery disease (CAD) represents a major health problem and a leading cause of
morbidity and mortality worldwide. It can manifest as acute coronary syndrome (ACS) …

Введение Доказательная фармакотерапия-часть доказательной медицины
Доказательная фармакотерапия использует основные методы доказательной …

Highlights of Acute Coronary Syndromes - PMC Back to Top Skip to main content NIH NLM
Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation …

In the year 2022 a large number of remarkable scientific papers were published in the field
of heart failure and heart muscle disease, to which the Hungarian Heart Failure community …

Такая практика применения антиаритмических препаратов существовала не менее 2-х
десятилетий, однако получение результатов рандомизированного контролируемого …

A Síndrome Coronariana Aguda (SCA) é uma condição cardiovascular prevalente e uma
das principais causas de morbidade e mortalidade global. O Infarto Agudo do Miocárdio …